American Society of Clinical Oncology

SHERPA: White

People

  1. Postow
    Postow
  2. Coit
    Coit
  3. Panageas
    Panageas
  4. Shoushtari
    Shoushtari
  5. Busam
    Busam
  6. Momtaz
    Momtaz
  7. Strong
    Strong
  8. Brady
    Brady
  9. Brennan
    Brennan
  10. Janjigian
    Janjigian

Groups

  1. Melanoma Disease Management Team (302)
  2. Department of Medicine (229)
  3. Solid Tumor Oncology Division (215)
  4. Melanoma and Immunotherapeutics Service (156)
  5. Survivorship Research (120)
  6. Hematologic Malignancies, Division of (113)
  7. Surgery (103)
  8. GSK Faculty (99)
  9. Epidemiology and Biostatistics (94)
  10. Biostatistics Service (84)
Search Within
  1. "Melanoma Disease Management Team"
Formats
  1. Meeting Abstract (213)
  2. Journal Article (83)
  3. Editorial (3)
  4. Correspondence (2)
  5. Guidelines (1)
Groups
  1. Melanoma Disease Management Team (302)
  2. Department of Medicine (229)
  3. Solid Tumor Oncology Division (215)
  4. Melanoma and Immunotherapeutics Service (156)
  5. Survivorship Research (120)
  6. Hematologic Malignancies, Division of (113)

More Groups

People
  1. Michael Postow (92)
  2. Alexander Shoushtari (69)
  3. Daniel Coit (65)
  4. Jedd Wolchok (59)
  5. Katherine Panageas (40)
  6. Margaret Callahan (38)

More People

Years
  1. 2025 (4)
  2. 2024 (22)
  3. 2023 (23)
  4. 2022 (14)
  5. 2021 (17)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (287)
  2. JCO Precision Oncology (11)
  3. American Society of Clinical Oncology Educational Book (3)
  4. Journal of Oncology Practice (1)

Results (302)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes after radiation for oligoprogressive disease sites in patients with EGFR-mutant lung cancer treated with osimertinib
    Journal Article

    Chen, M. F.; Jeng, M. Y.; Ma, J.; Agrawal, P.; Dunne, E.; Boe, L. A.; Kris, M. G.; Huang, J.; Veeraraghavan, H.; Gomez, D.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Comparative analysis of intracranial response assessment criteria in patients with melanoma brain metastases treated with combination nivolumab 1 ipilimumab in CheckMate 204
    Journal Article

    Huang, R. Y.; Youssef, G.; Nelson, T.; Wen, P. Y.; Forsyth, P.; Hodi, F. S.; Margolin, K.; Algazi, A. P.; Hamid, O.; Lao, C. D.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Evaluation and surgical management of pediatric cutaneous melanoma and atypical spitz and non-spitz melanocytic tumors (melanocytomas): A report from Children's Oncology Group
    Journal Article

    Sargen, M. R.; Barnhill, R. L.; Elder, D. E.; Swetter, S. M.; Prieto, V. G.; Ko, J. S.; Bahrami, A.; Gerami, P.; Karunamurthy, A.; Pappo, A. S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pooled long-term outcomes with nivolumab plus ipilimumab or nivolumab alone in patients with advanced melanoma
    Journal Article

    Long, G. V.; Larkin, J.; Schadendorf, D.; Grob, J. J.; Lao, C. D.; Márquez-Rodas, I.; Wagstaff, J.; Lebbé, C.; Pigozzo, J.; Robert, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • DNA methylation classes of stage II and III primary melanomas and their clinical and prognostic significance
    Journal Article

    Conway, K.; Edmiston, S. N.; Vondras, A.; Reiner, A.; Corcoran, D. L.; Shen, R.; Parrish, E. A.; Hao, H.; Lin, L.; Kenney, J. M.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Reply to M. Boileau et al
    Correspondence

    Barker, C. A.; Yom, S. S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy
    Meeting Abstract

    Zang, P. D.; Twardowski, P.; Chen, D. L.; Hall, E. T.; Hays, D.; Wilson, I.; Schmiedehausen, K.; Ferris, M.; Le, W.; Postow, M. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparison of clinical outcomes of stable disease with confirmed tumor reduction and RECIST partial response for tebentafusp in metastatic uveal melanoma (mUM)
    Meeting Abstract

    Ikeguchi, A.; Sato, T.; Butler, M. O.; Carvajal, R. D.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Nathan, P. D.; Piulats, J. M.; Johnson, D. B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarker analysis and updated clinical outcomes: Neoadjuvant systemic treatment (NST) with nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma
    Meeting Abstract

    Burton, E. M.; Wani, K. M.; Milton, D. R.; Segura, R. L.; Tetzlaff, M.; Ross, M. I.; Postow, M. A.; Glitza, I. C.; Wong, M. K. K.; Diab, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1/2 study to investigate the safety and efficacy of OBX-115 engineered tumor-infiltrating lymphocyte (TIL) cell therapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Schoenfeld, A. J.; Warner, A. B.; Chesney, J. A.; Thomas, S. S.; Hamid, O.; In, G. K.; Shoushtari, A. N.; Samhouri, Y.; Hari, P. N.; Ramsingh, G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save